Lihpao Life Science (Xiamen) Approved for COVID-19 Antibody Test


On August 18, Lihpao Biomedical (Xiamen) Medical Laboratory was approved to add new coronavirus antibody testing qualifications. At present, Leopard Gene can carry out combined detection of COVID-19 nucleic acid and antibody to increase the positive detection rate of carriers and reduce the risk of transmission of COVID-19.

[About COVID-19 Antibody Test] Antibody test which be used to rapid and preliminary screen for fever patients can increase the diagnosis rate of suspected cases.

For Instance, large-scale screening of asymptomatic people is conducive to early detection and can be used as a complement to nucleic acid detection. The antibody test can determine whether the person has been infected, which is useful for the investigation of the immune status of the research population.